[1]
Neves, D.V. et al. 2018. Therapeutic Doses of Eltrombopag do not Inhibit Hepatic BCRP in Healthy Volunteers: Intravenous Ceftriaxone as a Model. Journal of Pharmacy & Pharmaceutical Sciences. 21, 1 (Jun. 2018), 236–246. DOI:https://doi.org/10.18433/jpps29856.